Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article August 19 2025
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis
Research Article August 15 2025
The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHD
Research Article August 15 2025
Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group report
Research Article August 15 2025
Arterial human blood flow can be stopped by cables of VWF and platelets without coagulation
Research Article August 14 2025
Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study
Letter August 14 2025
A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse model
Research Article August 14 2025
Ectopic expression of BEX genes in T-cell Acute Lymphoblastic Leukemia
Research Article August 14 2025
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma
Research Article August 14 2025
Phase 2 Study of Relmacabtagene Autoleucel (CD19 CAR-T) for Relapsed/Refractory Mantle Cell Lymphoma in Chinese Adults
Review Article August 14 2025
Non-DLBCL Monomorphic and Hodgkin Lymphoma PTLD: Clinical Insights and Treatment Strategies
Letter August 14 2025
Priapism Before and After Hematopoietic Stem Cell Therapy in Individuals with Sickle Cell Disease
Research Article August 12 2025
Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis
Review Article August 12 2025
Efficacy of Eculizumab Discontinuation in Atypical Hemolytic Uremic Syndrome: A Systematic Review and Meta-analysis
Research Article August 12 2025
Sustained Survival Benefit of Emicizumab and Postponed Immunosuppression in Acquired Hemophilia A
Research Article August 12 2025
Progressive Silent Cerebral Infarction is Associated with Stroke and Persistent Cognitive Impairment in iTTP Survivors
Research Article August 8 2025
Accelerating Novel Therapies for Sickle Cell Disease with RWE: ASH RC Data Hub as a Strategically Coordinated Registry Network
Letter August 8 2025
NKTR-255 Enhances Complete Response Following CD19 CAR-T in Patients with Relapsed/Refractory Large B-cell Lymphoma
Research Article August 5 2025
Outcomes of CAR T-cells therapy in High-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis
Research Article August 5 2025
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis
Letter August 5 2025
Mini-Hyper-CVD plus Venetoclax and Navitoclax for Relapsed/Refractory Acute Lymphoblastic Leukemia
Research Article August 5 2025
Characteristics and outcomes of Kaposi sarcoma herpesvirus (KSHV)-associated inflammatory cytokine syndrome (KICS)
Research Article August 5 2025
Modification of Belantamab Mafodotin Dosing to Balance Efficacy and Tolerability in the DREAMM-7 and DREAMM-8 Trials
Research Article August 5 2025
Safety and Efficacy of Daratumumab in Immune Thrombocytopenia
Letter August 4 2025
Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia
Research Article August 4 2025
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II Study
Letter July 30 2025
ASH Sickle Cell Disease CPKD Guidelines Report
Research Article July 28 2025
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL
Research Article July 16 2025
The immune receptor FcRg-chain mediates CD36-induced platelet activation and thrombosis by oxidised low-density lipoproteins.
Research Article July 16 2025
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections and survival after CART in R/R LBCL
Research Article July 2 2025
Mitochondrial iron transport via MFRN1 is required for erythroid cell cycle progression
Research Article July 1 2025
Comparative Infection Risk in CAR T vs Bispecific Antibodies in B cell Lymphoma: A Systematic Review and Meta-Analysis
Research Article June 17 2025
Severe Parvovirus B19 Infection in Patients with Sickle Cell Disease Hospitalized in Intensive Care Unit
Page 4 of 4

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals